Skip to main content
Log in

Epstein-Barr virus infection in HIV-positive patients

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The relationship between Epstein-Barr virus (EBV) viral load in peripheral blood and HIV infection was determined in 103 HIV-infected patients. Epstein-Barr virus was detected by polymerase chain reaction in 75 % of the patients, 21 % of whom had the more uncommon EBV subtype 2. The highest levels of EBV were found in patients with 100–400 CD4+ cells/mm3 and not in those with more profound immunosuppression. An association was identified between EBV load and HIV proviral levels (p<0.0001), an IgM response to EBV early antigens (p≤0.01) and p24 antigenemia (p<0.01 in patients with > 100 CD4+ cells), but not with other clinical or laboratory parameters. Combinations of different EBV and HIV parameters identified a subgroup of patients with a 2.2- to 4.8-fold risk of ≥ 35 % decline in CD4+ counts over six months. The association between EBV and HIV markers may reflect a significant pathogenic interaction between the two viruses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. MacMahon E, Glass J, Hayward S, Mann R, Becker P, Charade P, McArthur J, Ambinder R Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991, 338: 969–973.

    Article  PubMed  Google Scholar 

  2. Greenspan J, Greenspan D, Lennette E, Abrams D, Conant M, Petersen V, Freese U Replication of Epstein-Barr virus within the epithelial cells of oral hairy leukoplaquia, an AIDS-associated lesion. New England Journal of Medicine 1985, 313: 1564–1571.

    PubMed  Google Scholar 

  3. Koval V, Clrck C, Vaishnav M, Spector S, Spector D Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. Journal of Virology 1991, 65: 6969–6978.

    PubMed  Google Scholar 

  4. Laurence J, Astrin S Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proceedings of the National Academy of Sciences of the USA 1991, 88: 7635–7639.

    PubMed  Google Scholar 

  5. Kenney S, Kamine J, Markovitz D, Fenrick R, Pagano J An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proceedings of the National Academy of Sciences of the USA 1988, 85: 1652–1656.

    PubMed  Google Scholar 

  6. Pagano J, Kenney S, Markovitz D, Kamine J Epstein-Barr virus interactions with human retroviruses. Journal of Virological Methods 1988, 21: 229–239.

    Article  PubMed  Google Scholar 

  7. Rahman M, Kingsley L, Atchison R, Belle S, Breinig M, Ho M, Rinaldo C Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. Journal of Clinical Microbiology 1991, 29: 1215–1220.

    PubMed  Google Scholar 

  8. Schattner A, Hanuka N, Sarov B, Sarov I, Handzel Z, Bentwich Z Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HN seroconversion. Clinical and Experimental Immunology 1991, 85: 209–213.

    PubMed  Google Scholar 

  9. Marèchal V, Nicolas J, Joah I, Costagliola D, Lefrère J Epstein-Barr virus transactivator antibodies in HIV infection. Lancet 1991, 338: 574.

    Article  Google Scholar 

  10. Birx D, Redfield R, Tosato G Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome or AIDS-related disorders. New England Journal of Medicine 1986, 314: 874–879.

    PubMed  Google Scholar 

  11. Sixbey J, Shirley P, Chesney P, Buntin D, Resnick L Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989, ii: 761–765.

    Article  Google Scholar 

  12. Sculley T, Cross S, Borrow P, Cooper D Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. Journal of Infectious Diseases 1988, 158: 186–192.

    PubMed  Google Scholar 

  13. Kyaw M, Hurren L, Evans L, Moss D, Cooper D, Benson E, Esmore D, Sculley T Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Research and Human Retroviruses 1992, 8: 1869–1874.

    PubMed  Google Scholar 

  14. Swiss HIV Cohort Study Coordinating Center Documentation of the Swiss Cohort Study. Eidgenössische Drucksachen-Materialzentrale, Berne, 1991.

    Google Scholar 

  15. Kawsaki E Sample preparation from blood, cells, and other fluids. In: Innis D, Gelfand D, Sninsky J, White T (ed): PCR protocols: a guide to methods and applications. Academic Press, San Diego, 1990, p. 146–152.

    Google Scholar 

  16. Telenti A, Marshall W, Smith T Detection of Epstein-Barr virus by the polymerase chain reaction. Journal of Clinical Microbiology 1990, 28: 2187–2190.

    PubMed  Google Scholar 

  17. Telenti A Detection and typing of Epstein-Barr virus by the polymerase chain reaction. In: Persing D, Tenover F, White T, Smith T (ed): Diagnostic molecular microbiology. American Society for Microbiology Washington DC, 1993, p. 344–349.

    Google Scholar 

  18. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. Journal of Virology 1990, 64: 4084–4092.

    PubMed  Google Scholar 

  19. Sixbey J, Shirley P, Sloas M, Raab-Traub N, Israele V A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection. Journal of Infectious Diseases 1991, 163: 1008–1015.

    PubMed  Google Scholar 

  20. Ou C, Kwok S, Mitchell S, Mack D, Sninsky J, Krebs J, Feorino P, Warfield D, Schochetman G DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 1988, 239: 295–297.

    PubMed  Google Scholar 

  21. Telenti A, Imboden P, Germann D Competitive polymerase chain reaction using an internal standard: application to the quantitation of viral DNA. Journal of Virological Methods 1992, 39: 259–268.

    Article  PubMed  Google Scholar 

  22. Gorgievski-Hrisoho M, Hinderer W, Nebel-Schickel H, Horn J, Vornhagen R, Sonneborn H, Wolf H, Siegl G Serodiagnosis of infectious mononucleosis by using a recombinant Epstein-Barr virus antigens and enzyme-linked immunosorbent assay technology. Journal of Clinical Microbiology 1990, 28: 2305–2311.

    PubMed  Google Scholar 

  23. Saah A, Munoz A, Kuo V, Fox R, Kaslow R, Phair J, Rinaldo C, Detels R, Polk B Predictors of the risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency virus type 1: a report from the multicenter AIDS cohort study. American Journal of Epidemiology 1992, 135: 1147–1155.

    PubMed  Google Scholar 

  24. Morris J, Gardner M Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates. In: Gardner M, Altman D (ed): Statistics with confidence. Universities Press, Belfast 1989, p. 50–63.

    Google Scholar 

  25. Magrath I Infectious mononucleosis and malignant neoplasia. In: Schlossberg D (ed): Infectious mononucleosis. Springer, New York 1989, p. 142–171.

    Google Scholar 

  26. Katz B, Raab-Traub N, Miller G Latent and replicative forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. Journal of Infectious Diseases 1989, 160: 589–598.

    PubMed  Google Scholar 

  27. Katz B, Saini U Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders. American Journal of Pathology 1992, 140: 1247–1254.

    PubMed  Google Scholar 

  28. Chow KC, Nacilla N, Witzig T, Li CY Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridization. American Journal of Hematology 1992, 41: 270–275.

    PubMed  Google Scholar 

  29. Zon L, Groopman J Hematological manifestations of the human immunodeficiency virus. Seminars in Hematology 1988, 25: 208–218.

    PubMed  Google Scholar 

  30. Groopman J Management of the hematological complications of the human immunodeficiency virus infection. Reviews of Infectious Diseases 1990, 12: 931–937.

    PubMed  Google Scholar 

  31. Cohen J, Wang F, Mannick J, Kieff E Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proceedings of the National Academy of Science of the USA 1989, 86: 9558–9562.

    Google Scholar 

  32. Yao Q, Rowe M, Young L, Rickinson A The Epstein-Barr virus carrier state: dominance of a single growth transforming isolate in the blood and in the oropharynx of healthy virus carriers. Journal of General Virology 1991, 72: 1579–1590.

    PubMed  Google Scholar 

  33. Rickinson A, Young L, Rowe M Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus transformed B cells. Journal of Virology 1987, 61: 1310–1317.

    PubMed  Google Scholar 

  34. Boyle M, Sewell W, Sculley T.Apolloni A, Turner J, Swanson C, Penny R, Cooper D Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991, 78: 3004–3011.

    PubMed  Google Scholar 

  35. Moss D, Misko I, Burrows S, Burman K, McCarthy R, Sculley T Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 1988, 331: 719–721.

    Article  PubMed  Google Scholar 

  36. Israele V, Shirley P, Sixbey J Excretion of Epstein-Barr virus from the genital tract of men. Journal of Infectious Diseases 1991, 163: 1341–1343.

    PubMed  Google Scholar 

  37. Naher H, Gissmann L, Freese U, Petzoldt D, Helfrich S Subclinical Epstein-Barr virus infection of both the male and female genital tract. Indication for sexual transmission. Journal of Investigative Dermatology 1992, 98: 791–793.

    Article  PubMed  Google Scholar 

  38. Rowe M, Young L, Crocker J, Stokes H, Henderson S, Rickinson A Epstein-Barr virus-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. Journal of Experimental Medicine 1991, 173: 147–158.

    Article  PubMed  Google Scholar 

  39. Centers for Disease Control Opportunistic non-Hodgkin's lyphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy — United States. Morbidity and Mortality Weekly Report 1991, 40: 591–600.

    Google Scholar 

  40. Subar M, Neri A, Inghirami G, Knowles D, Dalla-Favera R Frequentc-myc oncogen activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988, 72: 667–671.

    PubMed  Google Scholar 

  41. Ballerini P, Gaidano G, Gong J, Tassi V, Saglio G, Knowles D, Dalla-Favera R Molecular pathogenesis of HIV-associated lymphomas. AIDS Research and Human Retroviruses 1992, 8: 731–735.

    PubMed  Google Scholar 

  42. Niedobitek G, Herbst H, Young L, Brooks L, Masucci M, Crocker J, Rickinson A, Stein H Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 1992, 79: 2520–2526.

    PubMed  Google Scholar 

  43. Yerly S, Chamot E, Hirschel B, Perrin L Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunological parameters. Journal of Infectious Diseases 1992, 166: 269–276.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Telenti, A., Uehlinger, D.E., Marchesi, F. et al. Epstein-Barr virus infection in HIV-positive patients. Eur. J. Clin. Microbiol. Infect. Dis. 12, 601–609 (1993). https://doi.org/10.1007/BF01973638

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01973638

Keywords

Navigation